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Edited by Laszlo NagyAbstract CRM1, 14-3-3 proteins, and CaMK play important
roles in traﬃcking of HDAC7, but the interplay between these
proteins in this process is not clearly understood. Here, we show
that CRM1 is capable of promoting cytoplasmic localization of
wild-type and mutant HDAC7 (S178A/S344A/S479A), which is
normally found in the nucleus. Using phospho-speciﬁc antibodies
to HDAC7, we demonstrate that CaMK I promotes phosphory-
lation of S178, S344, and S479 of HDAC7. We also show that
endogenous S178-phosphorylated HDAC7 is localized in both
the nucleus and the cytoplasm, whereas S344- and S479-phos-
phorylated HDAC7 are exclusively localized in the nucleus. An
HDAC7 mutant, S178E/S344E/S479E, which lost the ability
to bind 14-3-3s, is localized in both the nucleus and the cyto-
plasm. Furthermore, the nuclear export of S178E/S344E/
S479E is inhibited by LMB, but is enhanced by the CRM1.
Taken together, these results strongly suggest that CRM1 med-
iated-nuclear export of HDAC7 is independent of HDAC7
phosphorylation and its association with 14-3-3s.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Histone acetylation and deacetylation play pivotal roles in
transcriptional regulation through remodeling local chromatin
structure and recruitment of positive or negative transcription
factors [1–4]. This reversible histone modiﬁcation is catalyzed
by a set of histone acetyltransferases (HATs) and histone
deacetylases (HDACs) [5,6]. There is increasing evidence that
HATs and HDACs also modify non-histone proteins to mod-
ulate the DNA-binding activity of transcription factors or pro-
tein–protein associations [7,8].
Histone deacetylases can be grouped into three classes based
on sequence homology in the catalytic domain, size, and sub-
cellular localization [9]. Class II HDACs including HDAC4,*Corresponding author. Fax: +1 216 368 3419.
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doi:10.1016/j.febslet.2006.08.038-5, -6, -7, -9, and -10 can be further divided into two subgroups
based on sequence similarity of their catalytic domains and
organization of their functional domains [10]. HDAC4, -5,
-7, and -9 (referred as class IIa HDACs hereafter) share a
highly homologous C-terminal catalytic domain with an over-
all 80% sequence identity. The C-terminus of HDAC7 has been
shown to associate with transcriptional co-repressors, such as
SMRT, N-CoR, mSin3A, and transcription factor HIF1a
[11–13]. The amino-terminal region of class IIa HDACs con-
tains limited but signiﬁcant sequence homology and has been
shown to be responsible for HDAC association with Cabin,
CtBP, MEF2, CaMK I/IV, HP1a, and 14-3-3s [10]. An impor-
tant feature of the class IIa HDACs is their ability to shuttle
between the nucleus and the cytoplasm. Precise regulation of
the subcellular distribution of class IIa HDACs plays a pivotal
role in cellular processes and organ development, including
muscle diﬀerentiation [14–16], heart development [17], thymus
development [18], and skeletogenesis [19].
The subcellular localization of class IIa HDACs has been
shown to be regulated by conserved serine residues and CaMK
I/IV since ectopic expression of CaMK I/IV promotes cyto-
plasmic distribution and mutation of these conserved serine
residues abolishes this activity [12,20]. In addition to CaMKs,
protein kinase D family kinases and Mirk/dyrk1B also play a
role in subcellular distribution of class IIa HDACs [21–25].
Nonetheless, it is not clear whether phosphorylation of these
conserved residues is essential for nuclear export of HDAC7.
14-3-3s, a family of basic proteins with diverse physiological
functions, are also implicated in the shuttling of class IIa
HDACs. We previously showed that serine to alanine muta-
tions (S178A/S344A/S479A) disrupt 14-3-3 binding sites and
abolish cytoplasmic localization of HDAC7 [12], suggesting
a role of the 14-3-3 binding sites in cytoplasmic retention of
HDAC7. However, whether 14-3-3 binding is suﬃcient or
essential for nuclear export of HDAC7 remained unclear. In
addition to 14-3-3s and CaMK I/IV, CRM1 also plays a role
in nucleocytoplasmic shuttling of class IIa HDACs. CRM1 is
an integral component of the nuclear export machinery that
is known to participate in nuclear export of many cellular pro-
teins. Treatment of cells with LMB, a CRM1-speciﬁc inhibitor,
restricts localization of class IIa HDACs to the nucleus [12,26].
Nevertheless, the interplay between these factors in subcellular
distribution of HDAC7 remains unclear.
In this study, we generated mutants that aﬀect the subcellu-
lar distribution of HDAC7 and used these mutants to examine
the roles of CRM1, CaMK I, and 14-3-3s in nucleocytoplasmication of European Biochemical Societies.
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phosphorylated HDAC7 and determine their native subcellu-
lar localization. Our results provide new insights into the
multiple mechanisms that mediate the delicate balance in sub-
cellular distribution of HDAC7.2. Materials and methods
2.1. Plasmid construction
Site-directed mutagenesis was carried out to generate HDAC7 mu-
tants, S178E/S344E/S479E, DNLS (in which amino acids 183–212 were
removed), and L915A/V917A according to manufacturer’s protocol
(Invitrogen). All constructs were veriﬁed by DNA sequencing. Dele-
tion and truncation constructs were generated by PCR.
2.2. Generation of HDAC7 antibodies
HDAC7 antibodies were raised using peptide sequence derived from
amino acids 115–129 (N-VILKKQQAALERTVH-C) of mHDAC7.
The antibodies do not cross-react with HDAC4 or HDAC5 (Supple-
mentary Figure 1). Phosphopeptide antisera against pS178, pS344,
and pS479 of HDAC7 were generated by injecting rabbits with phos-
phorylated peptides, N-FPLRKTVpSEPNLKLR-C, N-RPLNRTR-
pSEPLPPSA-C, or N-RPLSRTQpSSPAAPVS-C (ABR Inc.). Sera
were subjected to double puriﬁcation using non-phospho- and phos-
pho-peptide conjugated columns.
2.3. Immunoﬂuorescence microscopy
Immunostaining was conducted according to our previously pub-
lished protocol [11]. For peptide competition experiments, HeLa cells
grown on coverslips in 12-well plates were washed with 1· PBS and
ﬁxed in 3.7% paraformaldehyde. Fixed cells were washed with 1·
PBS and permeabilized with 1· PBS containing 1% Triton X-100
and 10% goat serum. The cells were blocked with 1· PBST containing
10% goat serum and incubated with the phospho-speciﬁc HDAC7
antibody, which were pre-incubated with or without 200-fold molar ex-
cess of the phosphorylated or non-phosphorylated peptides for 2 h at
room temperature. Following the primary antibody incubation, cells
were rinsed with 1· PBS and then incubated with an anti-rabbit IgG
conjugated with Alexa 488 (Molecular Probes). After three washes,
DAPI was applied to the samples to visualize cell nuclei. Images were
acquired using a LEICA ﬂuorescence microscope equipped with a
camera.
2.4. Confocal microscopy
HeLa cells were plated in 12-well plates (Nunc) and transfected using
Lipofectamine (Invitrogen) according to the manufacturer’s protocol.
For co-transfection, plasmids encoding HA-CRM1 and FLAG-
HDAC7 or HA-CaMK I and FLAG-HDAC7 were co-transfected into
HeLa cells. Transfected cells were ﬁxed in 3.7% paraformaldehyde
(PFA) in 1· PBS for 30 min at room temperature and permeabilized
with 1· PBS with the addition of 0.1% Triton X-100 and 10% goat ser-
um for 10 min. The cells were washed three times with PBS and incu-
bated in a 1· PBS containing goat serum (10%) and 0.1% Tween-20
solution (ABB) for 60 min. Incubation with primary antibodies was
carried out for 120 min ABB. The cells were washed three times in
PBS, and the secondary antibodies were added for 30–60 min in the
dark, at room temperature in ABB. Cover slips were mounted to slides
using Vectashield mounting medium with DAPI (H-1200, Vector Lab-
oratories, Inc.). All confocal images were acquired using a Zeiss LSM
510 inverted laser-scanning confocal microscope. A 63· numerical
aperture of 1.4 oil immersion planapochromat objective was used for
all experiments. For transfected HDAC7, images of Alexa Fluor 488
were collected using a 488-nm excitation light from an Argon laser, a
488-nm dichroic mirror and 500–550-nm band pass barrier ﬁlter. All
DAPI stained nuclear images were collected using a Coherent Mira-
F-V5-XW-220 (Verdi 5 W) Ti-Sapphire laser tuned at 750-nm, a 700-
nm dichroic mirror and a 390–465 nm band pass barrier ﬁlter. The
primary antibodies used were a-FLAG rabbit polyclonal (Sigma). The
secondaryantibodieswerea-rabbitAlexaFluor 488 (MolecularProbes).
All images were taken at the same time using same settings. Fig. 1C is
used as a control for all HDAC7 mutants described in Figs. 2–5.2.5. Coimmunoprecipitation
Transient transfection and coimmunoprecipitation were carried out
according to our published protocol [12]. Cells were transfected with
10 lg of the appropriate plasmids using Lipofectamine (Invitrogen).
Cells were harvested 48 h later and lysed in NET-N buﬀer (50 mM
Tris, pH 8.0, 150 mM NaCl, 10% glycerol, 0.5% NP-40, 1 mM PMSF
and protease inhibitors cocktail (Roche)) for 15 min at 4 C, scraped,
and centrifuged 15 min at 13000 rpm. The supernatant was kept as
whole cell extract. After pre-clearing by incubation with protein A/G
agarose (Pharmacia), immunoprecipitations were carried out using
anti-FLAG antibody-conjugated agarose (Sigma) for 2 h at 4 C.
Beads were washed 3–4 times with a lysis buﬀer. Immunoprecipitates
were heat denatured in SDS loading buﬀer, separated on SDS–PAGE,
transferred to a nitrocellulose membrane and probed with appropriate
antibodies. Anti-FLAG antibodies were purchased from Sigma. Anti-
14-3-3 and anti-HA antibodies were purchased from Santa Cruz Bio-
tech and Roche, respectively.
2.6. GST pull-down assays
Expression plasmid encoding FLAG-HDAC7 (WT) or FLAG-
HDAC7 (S178E/S344E/S479E) was transfected into HeLa cells. Whole
cell extracts were prepared, pre-cleared, and incubated with immobi-
lized GST-14-3-3e fusion protein. After several washes, retained frac-
tions were subjected to Western blotting with anti-FLAG antibodies.
2.7. Yeast two-hybrid assays
Yeast two-hybrid assays were conducted according to our published
protocol [11]. pGBT9-HDAC7 (or pGBT9), and pGAD-14-3-3e or
pGAD-MEF2A were co-transformed into yeast strain Y190 cells. b-
Galactosidase liquid assays were performed according to manufac-
turer’s protocol (Clontech). For viability assays, 500 transformed yeast
cells were spotted on -Trp-Leu and -Trp-Leu-His + 25 mM 3-AT as
indicated. HIS3 gene, whose expression depends on interaction of
the partners encoded by the two plasmids, is used to select colonies
expressing two interacting partners on plates containing -Trp-Leu-
His + 25 mM 3-AT.3. Results
To examine the subcellular distribution of endogenous
HDAC7, we employed immunoﬂuorescence microscopy using
anti-HDAC7 antibodies. Our data indicate that endogenous
HDAC7 is primarily localized in the nucleus with a small frac-
tion in the cytoplasm of HeLa cells (Fig. 1A, panels a–c). A
full-length (2–938) FLAG epitope-tagged HDAC7 expression
vector, FLAG-HDAC7, was transfected into HeLa cells and
immunoﬂuorescence microscopy was conducted to visualize
the subcellular localization of transfected FLAG-HDAC7.
We found that FLAG-HDAC7 has a similar subcellular distri-
bution pattern to that of the endogenous HDAC7 (panels d–f).
Mouse HDAC7 harbors an amino-terminal non-catalytic
domain that shares limited homology with other members of
the class IIa HDACs and a conserved carboxyl-terminal cata-
lytic domain (Fig. 1B). In order to further dissect the sequences
involved in nucleocytoplasmic shuttling of HDAC7, truncated
or deleted mutants were generated. These expression plasmids
were transfected into HeLa cells and their subcellular localiza-
tion was examined by confocal microscopy using anti-FLAG
antibodies. As a control, we also examined the wild-type
FLAG-HDAC7 by confocal microscopy. Consistent with
Fig. 1A, confocal microscopy demonstrates that wild-type
HDAC7 is primarily localized in the nucleus of HeLa cells
(Fig. 1C, panels a–c). We also found that HDAC7 (2–533),
which lacks HDAC catalytic domain, is predominately local-
ized in the nucleus (panels d–f), indicating that the ﬁrst 533
amino acids of HDAC7 are suﬃcient for nuclear localization.
Fig. 1. Subcellular distribution of endogenous and transfected HDAC7. (A) Immunoﬂuorescence microscopy of endogenous (panels a–c) and
transfected (panels d–f) HDAC7 in HeLa cells. (B) A schematic representation of mouse HDAC7. The functional domains of HDAC7 including the
HDAC catalytic domain are indicated. Ser 178, 344, and 479 are putative phosphorylation residues by CaMK I. We have shown that mutation of
these serines disrupts the association of HDAC7 with 14-3-3s [12]. (C) Confocal microscopy of wild-type FLAG-HDAC7, (panels a–c), FLAG-
HDAC7 (2–533) (panels d–f) and FLAG-HDAC7 (500–938) (panels g–i). (D) Subcellular localization of FLAG-HDAC7 (DNLS) (panels a–c) and
FLAG-HDAC7 (L915A/V917A) (panels d–f). HeLa cells were transfected with the indicated plasmids and the subcellular localization of HDAC7
was detected by confocal microscopy using anti-FLAG antibodies as described in ‘‘Section 2’’. Scale bar, 50 lm.
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cytoplasm (panels g–i), further implying that a putative
nuclear localization sequence (NLS) is present within amino
acids 2–533 of HDAC7. We also perform site-directed muta-
genesis by removing the putative NLS (amino acids 183–
191), DNLS, and to examine its subcellular distribution by
laser scanning confocal microscopy. Consistent with sequence
analyses, HDAC7 (DNLS) was exclusively localized to the
cytoplasm (Fig. 1D, panels a–c). Our previous observation
that nuclear export of HDAC7 is inhibited by LMB [12] sug-
gests a nuclear export sequence (NES) involved in nuclear ex-
port of HDAC7. We generated mutation in the putative NES
(L915A/V917A) and examined its subcellular localization and
found that HDAC7 (L915A/V917A) was exclusively nuclear
(panels d–f).4. CRM1 promotes nuclear export of HDAC7
Our inhibitor and mutation studies suggest that CRM1 reg-
ulates the subcellular distribution of HDAC7 [12]. We rea-
soned that if CRM1 were involved in nucleocytoplasmic
shuttling of HDAC7, ectopic expression of CRM1 would pro-
mote cytoplasmic accumulation of HDAC7. To test this
hypothesis, we co-transfected CRM1 and FLAG tagged
wild-type HDAC7 expression plasmids and examined the sub-cellular localization of HDAC7. We found that in the presence
of exogenous CRM1 expression plasmid (Fig. 2A, panels a–c)
but not vector alone (panels d–f),  35% of the transfected
cells display cytoplasmic and 45% of the cells exhibit nuclear/
cytoplasmic staining of HDAC7. We further examined
whether the NES mutation, L915A/V917A, had any eﬀect on
CRM1-mediated cytoplasmic localization of HDAC7. As a
control, we co-transfected vector with mutant HDAC7,
HDAC7 (L915A/V917A), and examined its subcellular locali-
zation. We found that vector alone did not aﬀect the localiza-
tion of HDAC7 (L915A/V917A) (data not shown).
Furthermore, overexpression of CRM1 did not alter subcellu-
lar localization of HDAC7 (L915A/V917A) (panels g–i).
HDAC7 (S178A/S344A/S479A), in which putative CaMK I
phosphorylation sites have been mutated, is exclusively local-
ized in the nucleus [12]. If phosphorylation of HDAC7 by
CaMK I were essential for nuclear export, overexpression of
CRM1 should have no eﬀect on the subcellular localization
of HDAC7 (S178A/S344A/S479A). Fig. 2B shows that vector
alone did not eﬀect the subcellular localization of HDAC7
(S178A/S344A/S479A) (panels a–c). To our surprise, overex-
pression of CRM1 promoted cytoplasmic localization of
HDAC7 (S178A/S344A/S479A) (panels d–f). The statistical
data of the above experiments are shown in Fig. 2C. These
data indicate that overexpression of CRM1 is capable of pro-
moting nuclear export of HDAC7 regardless of its phosphor-
Fig. 2. The eﬀects of overexpressing CRM1 on subcellular distribution of HDAC7. (A) Eﬀects of overexpression of CRM1 on subcellular
distribution of HDAC7 (L915A/V917A). Panels a–c: FLAG-HDAC7 + HA-CRM1; d–f: FLAG-HDAC7 + HA vector alone; g–i: FLAG-HDAC7
(L915A/V917A) + HA-CRM1. (B) Eﬀects of overexpression of CRM1 on subcellular distribution of HDAC7 (S178A/S344A/S479A). Panels a–c:
FLAG-HDAC7 (S178A/S344A/S479A) + HA vector alone; d–f: FLAG-HDAC7 (S178A/S344A/S479A) + HA-CRM1. S-A: S178A/S344A/S479A.
Confocal microscopy was carried out similar to that of Fig. 1C. Scale bar, 50 lm. (C), Statistics of the eﬀects of CRM1 on subcellular distribution of
HDAC7.
Fig. 3. The eﬀects of CaMK I on the subcellular distribution of
HDAC7 (2–533) and HDAC7 (L915A/V917A). Confocal microscopy
of HDAC7 (WT) in the presence of a constitutively active CaMK I.
HA-CRM1 expression plasmid was co-transfected with wild-type
(panels a–c), HDAC7 (1–533) (panes d–f) or HDAC7 (L915A/V917A)
(panels g–i) expression plasmid and immunostaining and confocal
microscopy were carried out using anti-FLAG antibodies as described
in ‘‘Section 2’’. Scale bar, 50 lm.
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essential for this activity.
We have previously shown that CaMK I promoted cytoplas-
mic localization of HDAC7 [12], implying a role of CaMK I in
the subcellular distribution of HDAC7. We also showed thatmutation at Ser 178, 344, and 479 completely abolished cyto-
plasmic retention of HDAC7. This observation suggested that
these three Ser residues were critical for cytoplasmic retention
promoted by CaMK I. If these residues were fully responsible
for cytoplasmic retention of HDAC7, we anticipate that over-
expression of CaMK I would promote cytoplasmic retention
of HDAC7 (2–533) and HDAC7 (L915A/V917A). We tested
this possibility by co-transfecting a constitutively active form
of CaMK I and HDAC7 (2–533) or HDAC7 (L915A/
V917A) into HeLa cells. We found that, in contrast to its eﬀect
on wild-type HDAC7 (Fig. 3, panels a–c), overexpressed
CaMK I did not promote cytoplasmic retention of HDAC7
(2–533) (panels d–f) or HDAC7 (L915A/V917A) (panels g–i).
These data indicate that the eﬀects of CaMK I on serine resi-
dues 178, 344, and 479 are not suﬃcient for cytoplasmic local-
ization of HDAC7, but the C-terminal NES is essential for
CaMK I-mediated cytoplasmic distribution.
The above data suggest that phosphorylation of HDAC7 is
not essential for CRM1-mediated nuclear export of HDAC7.
To further characterize the role of phosphorylation in subcel-
lular distribution of HDAC7, we generated antibodies speciﬁ-
cally recognize phosphorylated S178, S344, and S479 of
HDAC7. Wild-type or mutant HA-HDAC7 expression plas-
mid was transfected into HeLa cells. Whole cell lysates were
prepared and Western blot analyses were carried out using
anti-HA, anti-pS178, anti-pS344, and pS479 antibodies.
Fig. 4A demonstrates that anti-pS178 antibodies reacted with
wild-type and HDAC7 mutants, S344A and S479A, but not
mutant S178A. Similarly, anti-pS344 and anti-pS479 reacted
with wild-type, but not mutant HDAC7 S344A and S479A,
respectively. Extracts treated with calf intestinal phosphatase
Fig. 4. Subcellular localization of phosphorylated HDAC7. (A) Characterization of phosphopeptide antibodies. (B) Speciﬁcity of phospho-speciﬁc
antibodies. HA-HDAC7 was expressed in HeLa cells and extracts prepared. Extracts were treated with (lane 2) or without (lane 1) calf intestinal
phosphatase (CIP) prior to SDS–PAGE. Western blotting were performed using anti-HA and anti-phospho-speciﬁc antibodies. (C) CaMK I
promotes phosphorylation of S178 and S479 of HDAC7. An expression plasmid of wild-type was transfected with or without a plasmid carrying a
constitutive active form of CaMK I into HeLa cells. Whole cell extracts were prepared followed by Western blotting with anti-HA, anti-pS178, anti-
pS344, or anti-pS479 antibodies. (D) Subcellular localization of S178-phosphorylated HDAC7. panels a–c: no competitor was added; d–f: non-
phosphorylated peptide was added for immunostaining; g–i: pS178-containing phosphorylated peptide was included for immunostaining. (E)
Subcellular localization of S344-phosphorylated HDAC7. Immunoﬂuorescence microscopy was performed similarly to (D). (F) Subcellular
localization of S344-phosphorylated HDAC7. Immunostaining was carried out similarly to D.
5100 C. Gao et al. / FEBS Letters 580 (2006) 5096–5104(CIP) exhibited signiﬁcant reduced signals (Fig. 4B). These
data indicate that anti-phosphopeptide antibodies speciﬁcally
recognize their cognate phosphopeptide antigens and that
mutation of the putative phosphorylated serine abolishes anti-
body recognition.We further tested whether co-expression of CaMK I pro-
motes phosphorylation of S178, S344, and S479 of HDAC7.
We found that co-expression of a constitutively active CaMK
I signiﬁcantly promoted phosphorylation of S178 and mod-
estly upregulated phosphorylation of S344 and S479
Fig. 5. Subcellular distribution of HDAC7 (S-E) mutant. The subcel-
lular localization of HDAC7 (S178E/S344E/S479E) (panels a–c) was
observed as described in Fig. 1. The eﬀects of LMB on subcellular
localization of HDAC7 (S178E/S344E/S479E) was recorded 1 h after
treated with 100 nM LMB (panels d–f). CRM1 expression plasmid was
co-transfected with HDAC7 (S178E/S344E/S479E) (panels g–i) to
evaluate the eﬀects of CRM1 on subcellular localization of HDAC7. S-
E: S178E/S344E/S479E. Confocal microscopy was performed similar
to that of Fig. 1C. Scale bar, 50 lm.
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promotes phosphorylation of S178, S344, and S479 of HDAC7
in mammalian cells.
We further investigated subcellular localization of endoge-
nous phosphorylated HDAC7 by immunoﬂuorescence micros-
copy using anti-pS178, anti-pS344, anti-pS479 antibodies.
Fig. 4D shows that Ser178-phosphorylated HDAC7 localizes
in both nucleus and cytoplasm (panels a–c). Interestingly, a
small amount of HDAC7 localizes in the plasma membrane.
This plasma membrane staining pattern is also observed in
cells co-transfected with HDAC7 and CRM1 (Fig. 2) or
CaMK I (Fig. 3). Addition of non-phosphorylated peptide
does not aﬀect staining pattern (panels d-f), whereas addition
of phosphorylated peptide signiﬁcantly abolishes nuclear as
well as plasma membrane staining (panels g–i). Furthermore,
both anti-pS344 and anti-pS479 antibodies show nuclear stain-
ing and the nuclear staining can be competed when phosphor-
ylated, but not non-phosphorylated peptide was added
(Fig. 4E and F). These data indicate that phosphorylation of
S178, S344, and S479 is not suﬃcient for nuclear export of
HDAC7.5. HDAC7 (S178E/S344E/S479E) localizes in both the
cytoplasm and the nucleus
We previously demonstrated that expression of a constitu-
tively active form of CaMK I promotes cytoplasmic distribu-
tion of HDAC7. We further showed that CaMK I enhances
association of 14-3-3 proteins with HDAC7 and promotes
nuclear export of HDAC7 [12,27]. These observations led to
the hypothesis that the interactions between 14-3-3s and class
IIa HDACs regulate subcellular distribution of class IIaHDACs. To further elucidate the roles of CaMK I and 14-3-
3 in nuclear export of HDAC7, we generated an HDAC7
mutant, S178E/S344E/S479E in which both the CaMK I/IV
phosphorylation sites and 14-3-3 bindings sites were mutated
to glutamic acids. We hypothesize that glutamic acid might
mimic the charge of phosphorylated serine, allowing HDAC7
to interact with 14-3-3s without CaMK I/IV activity. To test
this hypothesis, HDAC7 (S178E/S344E/S479E) expression
vector was transfected into HeLa cells. Anti-FLAG antibodies
were used to detect subcellular distribution of HDAC7 (S178E/
S344E/S479E) by confocal microscopy. Fig. 5 shows that
HDAC7 (S178E/S344E/S479E) was distributed in both the nu-
cleus and the cytoplasm (panes a–c).
To test whether the cytoplasmic distribution of FLAG-
HDAC7 (S178E/S344E/S479E) was mediated by CRM1, cells
were treated with LMB prior to confocal microscopy with
anti-FLAG antibodies. As shown in Fig. 5 (panels d–f),
HDAC7 (S178E/S344E/S349E) with an increased intensity
was predominantly localized in the nucleus after one-hour
treatment with LMB. Moreover, co-expression of CRM1 also
promoted a cytoplasmic distribution of HDAC7 (S178E/
S344E/S49E) (panels g–i). These data suggest that the cyto-
plasmic retention of HDAC7 (S178E/S344E/S49E) is mediated
by an active LMB-sensitive nuclear export mechanism, but not
due to the result of trapping of the mutant in the cytoplasm.
These data further suggest that phosphorylation of HDAC7
on S178, S344, or S479 is not essential for CRM1-mediated
nuclear export of HDAC7.6. S178E/S344E/S479E does not bind 14-3-3 in mammalian cells
Knowing that the HDAC7 (S178E/S344E/S479E) is capable
of localizing in the cytoplasm, we tested whether HDAC7
(S178E/S344E/S479E) was able to interact with 14-3-3s in
mammalian cells. To do so, we carried out immunoprecipita-
tion experiments (Fig. 6A). FLAG-tagged wild-type and
mutant HDAC7 (S178E/S344E/S479E) were transfected into
cells individually. Immunoprecipitation was conducted using
anti-FLAG antibodies, and followed by Western blot analyses
with 14-3-3 antibodies. Unexpectedly, mutant HDAC7
(S178E/S344E/S479E) lost its ability to interact with 14-3-3s
(lanes 2 and 4), while wild-type HDAC7 eﬃciently co-precipi-
tated endogenous 14-3-3s (lanes 1 and 3). GST pull-down
experiments were also carried out to examine the association
between HDAC7 (S178E/S344E/S479E) and GST-14-3-3e.
Consistently, we observed a signiﬁcant loss of interaction
between HDAC7 (S178E/S344E/S49E) and 14-3-3e (Fig. 6B).
In contrast, HDAC7 (S178E/S344E/S479E) was still able to
interact with SMRT as demonstrated by co-immunoprecipita-
tion experiments (Fig. 6C). These data suggest that HDAC7
(S178E/S344E/S479E) lost its ability to interact with 14-3-3s,
but not other interacting partners.
It is possible that the immunoprecipitation data is not sensi-
tive enough to detect the interaction of 14-3-3e with HDAC7
(S178E/S344E/S479E). To test this possibility, we quantiﬁed
the strength of the interaction between HDAC7 and 14-3-3e
by yeast two-hybrid assays. Fig. 6D shows that co-transforma-
tion of pGBT9-HDAC7 (WT) and pGAD-14-3-3e resulted in
an eighty-fold increase of the reporter activity, indicative of
a strong association between HDAC7 and 14-3-3e. As a con-
trol, HDAC7 (S178A/S344A/S479A) was included and did
Fig. 6. Association of HDAC7 with 14-3-3 s. (A) HDAC7 (S178E/S344E/S479E) does not interact with 14-3-3s. A FLAG-HDAC7 (wild-type or
mutant S178E/S344E/S479E) expression vector was transfected into cells. Whole cell extracts were prepared for immunoprecipitation using anti-
FLAG antibodies. Immunoprecipitates were subject to Western blot analyses probed with anti-14-3-3 antibodies. (B) GST-14-3-3s failed to interact
with HDAC7 (S178E/S344E/S479E). (C) HDAC7 (S178E/S344E/S479E) remains association with SMRT. Similar to (A) except HA-SMRT (1188–
1833) expression vector was co-transfected with HDAC7 expression vector. S-E: S178E/S344E/S479E. (D) b-Galactosidase liquid assays. Yeast cells
containing both pGBT9-HDAC7 (2–533) and pGAD-14-3-3e (lanes 2, 5, and 8) or pGAD-MEF2A (lanes 3, 6, and 9) expression plasmids were
assayed for their b-galactosidase activity according to manufacturer’s protocol (Clontech). Lanes 1–3: wild-type HDAC7; lanes 4–6: HDAC7
(S178A/S344A/S479A); lanes 7–9: HDAC7 (S178E/S344E/S479E) lane 10: pGAD-MEF2A alone. (E) Yeast selection plate viability assays. Yeast
cells expressing Gal4 DBD-HDAC7 (2–533) and Gal4-AD-14-3-3e or Gal4-AD-MEF2A fusion proteins were dotted on -Trp-Leu (left panel) or
-Trp-Leu-His + 25 mM 3-AT plate. S-A: S178A/S344A/S479A; S-E: S178E/S344E/S479E.
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action with 14-3-3e. Similarly, HDAC7 (S178E/S344E/S479E)
failed to activate reporter activity. This result indicates that
HDAC7 (S178E/S344E/S479E) did not interact with 14-3-3e.
One possibility that could account for the loss of the interac-
tion would be a signiﬁcant alteration in the conformation of
the mutant HDAC7. To test whether this was the case, we
examined the association of the mutant with MEF2s, which
interacts with amino acids 72–172 of HDAC7 [12]. As ex-
pected, wild-type HDAC7 (2–533) interacts strongly with
MEF2A (lane 3). In addition, both HDAC7 (S178A/S344A/
S479A) and HDAC7 (S178E/S344E/S479E) remained strongly
associated with MEF2A (lanes 6 and 9), suggesting that there
is a speciﬁc loss of interaction of HDAC7 (S178E/S344E/
S479E) with 14-3-3e. Furthermore, using a selection marker,
we demonstrated that while cells expressing AD-14-3-3e and
DBD-HDAC7 (2–533, WT) are viable, cells expressing AD-14-3-3e and DBD-HDAC7 (2–533, S178E/S344E/S479E) or
DBD-HDAC7 (2–533, S178A/S344A/S479A) did not survive
on the selecting plates (Fig. 6E), indicating no interactions oc-
curred between HDAC7 (S178E/S344E/S479E) and 14-3-3e.
Taken together, these data indicate that HDAC7 (S178E/
S344E/S479E) speciﬁcally loses its normal ability to interact
with 14-3-3e.7. Discussion
Nucleocytoplasmic traﬃcking of cellular proteins are gov-
erned by two distinct classes of short sequences: NLS and
NES [28]. The best-known NLSs harbor basic amino acids that
interact directly with importin b, or indirectly through their
association with importin a. The well-characterized NESs are
leucine-rich sequences that physically associate with CRM1,
C. Gao et al. / FEBS Letters 580 (2006) 5096–5104 5103an integral component of the nuclear export machinery. The
subcellular localization of class IIa HDACs is regulated by
both the N-terminal NLS and the C-terminal NES. The
mapped NLS and NES of HDAC7 are conserved among class
IIa HDACs [20,26,29]. In this study, we have generated
HDAC7 mutants and examined their subcellular distribution.
We also employed these mutants to examine the roles of
CaMK I, 14-3-3s, and CRM1 in the nucleocytoplasmic shut-
tling of HDAC7. Based on our ﬁndings, several conclusions
can be drawn. First, the C-terminal NES is essential for nucle-
ar export of HDAC7. Second, CaMK I potently stimulates
phosphorylation of S178 of HDAC7. Third, phosphorylation
of the conserved Ser 178, 344, and 479 is not required for
CRM1-mediated nuclear export of HDAC7. Lastly, the asso-
ciation of HDAC7 and 14-3-3 is dispensable for CRM1-med-
iated nuclear export of HDAC7.
Cytoplasmic localization of HDAC7 could be due to active
nuclear export or the inability to translocate into the nucleus.
Several lines of evidence support the notion that nuclear ex-
port of HDAC7 relies on the C-terminal NES and CRM1:
(1) mutation of the NES (L915A/V917A) completely abolishes
the nuclear export of HDAC7, resulting in exclusively nuclear
accumulation, (2) ectopic expression of CRM1 promotes a
cytoplasmic distribution of wild-type HDAC7, but not the
NES mutant or HDAC7 (2–533) (Fig. 3). Furthermore, our
data indicate that phosphorylation of the conserved Ser 178,
344, and 479 by CaMK I (and possibly PKD) [21,22,25] is
not required for CRM1-mediated nuclear export (Figs. 2B
and 5). Taken together, these data suggest that the kinases
including CaMKs and PKD [21,22,25] phosphorylate class
IIa HDACs and sequester them in the cytoplasm, blocking
their nuclear import. One possible mechanism is that Ser 178
(14-3-3 binding site) is closely adjacent to the NLS (amino
acids 183–191) and association of phosphorylated HDAC7
with 14-3-3s may mask recognition of the NLS by importin
a [30]. As such, the subcellular distribution of HDAC7 is cell-
and signal-dependent, based on the phosphorylation status of
S178.
Although HDAC7 (S178E/S344E/S479E), which has lost its
CaMK I target sites, has a similar distribution to wild-type
HDAC7, it did not interact with 14-3-3s. Phosphorylation
of serines 178, 344, and 479 controls the ability of HDAC7
to interact with 14-3-3s. We originally proposed that a muta-
tion from serine to glutamic acid may mimic the charge of
the phosphorylated serines. Our data clearly show that this
mutant does not interact with 14-3-3s, but is capable of local-
izing in the cytoplasm nonetheless. How is HDAC7 (S178E/
S344E/S479E) exported to the cytoplasm? Our inhibitor study
indicated that HDAC7 (S178E/S344E/S479E) enters the nu-
cleus and is exported to the cytoplasm in a CRM1-dependent
pathway. Furthermore, ectopic expression of CRM1 pro-
motes cytoplasmic localization of HDAC7 (S178E/S344E/
S479E). It is likely that although this mutant loses its ability
to interact with 14-3-3s, it still shuttles. Indeed, ectopic
expression of CRM1 promotes nuclear export of HDAC7
(S178A/S344/S479A). Taken together, these observations sug-
gest that cytoplasmic localization of HDAC7 (S178E/S344E/
S479E) does not require CaMK I and that 14-3-3 binding
is not absolutely required for CRM1-mediated nuclear export
of HDAC7.
Studies on the regulation of the subcellular distribution
of HDAC4 and HDAC5 have suggested distinct roles for14-3-3 binding sites in their nuclear export [20,26]. It appears
that the NES in HDAC5 requires phosphorylation at the N-
terminal 14-3-3 binding sites in order to be activated, whereas
an isolated fragment NES of HDAC4 is capable of functioning
on its own. Our ﬁndings on HDAC7 suggest that the control of
traﬃcking of class IIa HDACs may be regulated by distinct
mechanisms. It may provide a balance between kinases, 14-3-
3s, and CRM1 that regulate the activity of distinct members
of class IIa HDACs to respond appropriately to environmental
stimuli.
Acknowledgements: We thank Drs. Samols and Snider for their com-
ments on the manuscript. H.-Y. Kao is recipient of the James T. Par-
dee-Carl A. Gerstacker Assistant Professor of Cancer Research
Faculty Chair in Cancer Research at CWRU Cancer Center. This re-
search is supported by the Confocal Microscopy Core Facility of the
Comprehensive Cancer Center of Case Western Reserve University
and University Hospitals of Cleveland (P30 CA43703-12). This project
is supported by NIH/NIDDK, R01 DK62985 and American Heart
Association (033031N) to H.-Y. Kao.Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.febslet.2006.
08.038.References
[1] Ajiro, K. and Allis, C.D. (2002) Histone code hypothesis.
Tanpakushitsu Kakusan Koso 47, 753–760.
[2] Berger, S.L. (2002) Histone modiﬁcations in transcriptional
regulation. Curr. Opin. Genet. Dev. 12, 142–148.
[3] Jenuwein, T. and Allis, C.D. (2001) Translating the histone code.
Science 293, 1074–1080.
[4] Strahl, B.D. and Allis, C.D. (2000) The language of covalent
histone modiﬁcations. Nature 403, 41–45.
[5] De Ruijter, A.J., Van Gennip, A.H., Caron, H.N., Kemp, S. and
Van Kuilenburg, A.B. (2003) Histone deacetylases (HDACs):
characterization of the classical HDAC family. Biochem. J. 370,
737–749.
[6] Roth, S.Y., Denu, J.M. and Allis, C.D. (2001) Histone acetyl-
transferases. Annu. Rev. Biochem. 70, 81–120.
[7] Kouzarides, T. (2000) Acetylation: a regulatory modiﬁcation to
rival phosphorylation? Embo J. 19, 1176–1179.
[8] Sterner, D.E. and Berger, S.L. (2000) Acetylation of histones and
transcription-related factors. Microbiol. Mol. Biol. Rev. 64, 435–
459.
[9] Khochbin, S. and Kao, H. (2001) Histone deacetylase complexes:
functional entities or molecular reservoirs. FEBS Lett. 494, 141–
144.
[10] Verdin, E., Dequiedt, F. and Kasler, H.G. (2003) Class II
histone deacetylases: versatile regulators. Trends Genet. 19, 286–
293.
[11] Kao, H.Y., Downes, M., Ordentlich, P. and Evans, R.M. (2000)
Isolation of a novel histone deacetylase reveals that class I and
class II deacetylases promote SMRT-mediated repression. Genes
Dev. 14, 55–66.
[12] Kao, H.Y., Verdel, A., Tsai, C.C., Simon, C., Juguilon, H. and
Khochbin, S. (2001) Mechanism for nucleocytoplasmic shuttling
of histone deacetylase 7. J. Biol. Chem. 276, 47496–47507.
[13] Kato, H., Tamamizu-Kato, S. and Shibasaki, F. (2004) Histone
deacetylase 7 associates with hypoxia-inducible factor 1alpha and
increases transcriptional activity. J. Biol. Chem. 279, 41966–
41974.
[14] McKinsey, T.A., Zhang, C.L., Lu, J. and Olson, E.N. (2000)
Signal-dependent nuclear export of a histone deacetylase regulates
muscle diﬀerentiation. Nature 408, 106–111.
5104 C. Gao et al. / FEBS Letters 580 (2006) 5096–5104[15] McKinsey, T.A., Zhang, C.L. and Olson, E.N. (2000) Activation
of the myocyte enhancer factor-2 transcription factor by calcium/
calmodulin-dependent protein kinase-stimulated binding of 14-3-
3 to histone deacetylase 5. Proc. Natl. Acad. Sci. USA 97, 14400–
14405.
[16] Miska, E.A., Langley, E., Wolf, D., Karlsson, C., Pines, J. and
Kouzarides, T. (2001) Diﬀerential localization of HDAC4 orches-
trates muscle diﬀerentiation. Nucleic Acids Res. 29, 3439–3447.
[17] Zhang, C.L., McKinsey, T.A., Chang, S., Antos, C.L., Hill, J.A.
and Olson, E.N. (2002) Class II histone deacetylases act as signal-
responsive repressors of cardiac hypertrophy. Cell 110, 479–488.
[18] Dequiedt, F., Kasler, H., Fischle, W., Kiermer, V., Weinstein, M.,
Herndier, B.G. and Verdin, E. (2003) HDAC7, a thymus-speciﬁc
class II histone deacetylase, regulates Nur77 transcription and
TCR-mediated apoptosis. Immunity 18, 687–698.
[19] Vega, R.B., Matsuda, K., Oh, J., Barbosa, A.C., Yang, X.,
Meadows, E., McAnally, J., Pomajzl, C., Shelton, J.M., Rich-
ardson, J.A., Karsenty, G. and Olson, E.N. (2004) Histone
deacetylase 4 controls chondrocyte hypertrophy during skeleto-
genesis. Cell 119, 555–566.
[20] McKinsey, T.A., Zhang, C.L. and Olson, E.N. (2001) Identiﬁca-
tion of a signal-responsive nuclear export sequence in class II
histone deacetylases. Mol. Cell Biol. 21, 6312–6321.
[21] Vega, R.B., Harrison, B.C., Meadows, E., Roberts, C.R., Papst,
P.J., Olson, E.N. and McKinsey, T.A. (2004) Protein kinases C
and D mediate agonist-dependent cardiac hypertrophy through
nuclear export of histone deacetylase 5. Mol. Cell Biol. 24, 8374–
8385.
[22] Parra, M., Kasler, H., McKinsey, T.A., Olson, E.N. and Verdin,
E. (2004) Protein kinase D1 phosphorylates HDAC7 and Induces
its nuclear export after TCR activation. J. Biol. Chem. 280,
13762–13770.[23] Deng, X., Ewton, D.Z., Mercer, S.E. and Friedman, E. (2005)
Mirk/dyrk1B decreases the nuclear accumulation of class II
histone deacetylases during skeletal muscle diﬀerentiation. J. Biol.
Chem. 280, 4894–4905.
[24] Matthews, S.A., Liu, P., Spitaler, M., Olson, E.N., McKinsey,
T.A., Cantrell, D.A. and Scharenberg, A.M. (2006) Essential role
for protein kinase D family kinases in the regulation of class II
histone deacetylases in B lymphocytes. Mol. Cell Biol. 26, 1569–
1577.
[25] Dequiedt, F., Van Lint, J., Lecomte, E., Van Duppen, V.,
Seuﬀerlein, T., Vandenheede, J.R., Wattiez, R. and Kettmann, R.
(2005) Phosphorylation of histone deacetylase 7 by protein kinase
D mediates T cell receptor-induced Nur77 expression and
apoptosis. J. Exp. Med. 201, 793–804.
[26] Wang, A.H. and Yang, X.J. (2001) Histone deacetylase 4
possesses intrinsic nuclear import and export signals. Mol. Cell
Biol. 21, 5992–6005.
[27] Li, X., Song, S., Liu, Y., Ko, S.H. and Kao, H.Y. (2004)
Phosphorylation of the histone deacetylase 7 modulates its
stability and association with 14-3-3 proteins. J. Biol. Chem.
279, 34201–34208.
[28] Bednenko, J., Cingolani, G. and Gerace, L. (2003) Nucleocyto-
plasmic transport: navigating the channel. Traﬃc 4, 127–135.
[29] Petrie, K., Guidez, F., Howell, L., Healy, L., Waxman, S.,
Greaves, M. and Zelent, A. (2003) The histone deacetylase 9 gene
encodes multiple protein isoforms. J. Biol. Chem. 278, 16059–
16072.
[30] Grozinger, C.M. and Schreiber, S.L. (2000) Regulation of histone
deacetylase 4 and 5 and transcriptional activity by 14-3-3-
dependent cellular localization. Proc. Natl. Acad. Sci. USA 97,
7835–7840.
